An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages

  Ghanim, Husam ^a   Sia, Chang Ling ^a   Abuaysheh, Sanaa ^a   Korzeniewski, Kelly ^a   Patnaik, Priyanka ^a   Marumganti, Anuritha ^a   Chaudhuri, Ajay ^a   Dandona, Paresh ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PHOSPHOTYROSINE PHOSPHATASE 1B; PLACEBO; POLYGONUM CUSPIDATUM EXTRACT; PROTEIN P47; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; RNA; STRESS ACTIVATED PROTEIN KINASE 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN; LIPID; PLANT EXTRACT; STILBENE DERIVATIVE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING COMPETITION; BLOOD SAMPLING; CELL FREE SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; HUMAN; INFLAMMATION; MONONUCLEAR CELL; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; THERAPY EFFECT; TREATMENT DURATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; OXIDATIVE STRESS;

ANIMALIA; POLYGONUM CUSPIDATUM;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BLOOD GLUCOSE; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INSULIN; LEPTIN; LIPIDS; OXIDATIVE STRESS; PLACEBOS; PLANT EXTRACTS; POLYGONUM CUSPIDATUM; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 77956585215     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0482     Document Type: Article

References (32)

1. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG 1999 The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309-313
2. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P 2003 Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100:2112-2116
3. Shoelson SE, Lee J, Yuan M 2003 Inflammation and the IKKβ/IκB/ NF-κB axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27(Suppl 3):S49-S52
4. Orr WC, Sohal RS 1994 Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263:1128-1130
5. Hu D, Cao P, Thiels E, Chu CT, Wu GY, Oury TD, Klann E 2007 Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol Learn Mem 87:372-384
6. Sohal RS, Weindruch R 1996 Oxidative stress, caloric restriction, and aging. Science 273:59-63
7. Lee DW, Yu BP 1990 Modulation of free radicals and superoxide dismutases by age and dietary restriction. Aging (Milano) 2:357-362
8. Dandona P, Mohanty P, Hamouda W, Ghanim H, Aljada A, Garg R, Kumar V 2001 Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma orthotyrosine and meta-tyrosine concentrations. J Clin Endocrinol Metab 86:2899-2902
9. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R 2001 The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 86:355-362
10. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T 1998 Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
11. Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG 2005 Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-κB-independent mechanism. FASEB J 19:840-841
12. Rahman I, Biswas SK, Kirkham PA 2006 Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-1452 (Pubitemid 44666744)
13. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA 2003 Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196
14. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA 2008 A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3:e2264
15. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J 2006 Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127:1109-1122
16. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q 2007 SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307-319
17. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB 2008 Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283:14230-14241
18. Moller DE 2001 New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827
19. Hsu CY, Chan YP, Chang J 2007 Antioxidant activity of extract from Polygonum cuspidatum. Biol Res 40:13-21
20. Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, Dandona P 2004 Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 79:682-690
21. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P 2001 Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 86:1306-1312
22. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P 2004 Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 89:2728-2735
23. Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P 2006 Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab 91:3553-3558
24. Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E 2001 SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J Biol Chem 276:47944-47949
25. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA 2003 Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 278:13740-13746
26. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P 2007 Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 50:278-285
27. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867
28. Rui L, Yuan M, Frantz D, Shoelson S, White MF 2002 SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394-42398
29. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025
30. Ali MI, Ketsawatsomkron P, Belin de Chantemele EJ, Mintz JD, Muta K, Salet C, Black SM, Tremblay ML, Fulton DJ, Marrero MB, Stepp DW 2009 Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ Res 105:1013-1022
31. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP 1999 Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548
32. Biesalski HK 2007 Polyphenols and inflammation: basic interactions. Curr Opin Clin Nutr Metab Care 10:724-728